|
| ||||||||||||||||||||||||||||||||||||||||||||||||||
PEDIATRICS Vol. 107 No. 3 March 2001, pp. 598-601
AMERICAN ACADEMY OF PEDIATRICS:
Counseling Families Who Choose Complementary and Alternative
Medicine for Their Child With Chronic Illness or Disability
| |
ABSTRACT |
|---|
|
|
|---|
The use of complementary and alternative medicine (CAM) to treat chronic illness or disability is increasing in the United States. This is especially evident among children with autism and related disorders. It may be challenging to the practicing pediatrician to distinguish among accepted biomedical treatments, unproven therapies, and alternative therapies. Moreover, there are no published guidelines regarding the use of CAM in the care of children with chronic illness or disability. To best serve the interests of children, it is important to maintain a scientific perspective, to provide balanced advice about therapeutic options, to guard against bias, and to establish and maintain a trusting relationship with families. This statement provides information and guidance for pediatricians when counseling families about CAM.
The use of complementary and alternative medicine (CAM) is
increasing in Western countries. Indeed, more than one third of the
adults in the United States have used CAM in recent
years.1,2 Pediatric use of CAM is especially likely among
children with chronic illness or disability. Up to 50% of children
with autism in the United States probably are using some form of
CAM.3 In many instances, the physician providing medical
care is unaware of the concurrent use of CAM. Increasingly,
pediatricians providing care for children with chronic illness or
disability are discussing CAM with families or are asked to prescribe
such treatments. Pediatricians' expertise in biomedicine may not
adequately prepare them for discussion of CAM.
CAM has been defined as "a broad domain of healing resources
that encompasses all health systems, modalities, and practices and
their accompanying theories and beliefs, other than those intrinsic to
the politically dominant health system of a particular society or
culture in a given historic period."4 An enormous array
of unconventional therapies may be used as alternative therapies
(instead of conventional treatments) or as complementary therapies (in
addition to conventional treatments) (see Fig
1).
![]()
STATEMENT OF THE PROBLEM
![]()
BACKGROUND INFORMATION AND DEFINITIONAL ISSUES

View larger version (35K):
[in a new window]
Fig. 1.
Biopsychosocial medicine and alternative medicine are broad systems of
health care that encompass theories, practices, and therapies.
Integrative medicine is a term loosely used to describe these systems
used in combination. Therapies (whether biomedical, complementary, or
alternative) are considered proven or unproven based on a hierarchy of
evidence.
Currently, courses on CAM approaches are offered in the majority of US medical schools.5 The US government established the Office of Alternative Medicine (now the National Center for Complementary and Alternative Medicine) in the National Institutes of Health to carry out scientific study of CAM.6
Biomedicine is based on laws of science and the rigorous applications of the scientific method. It may aptly be called scientific medicine or evidence-based medicine. Disease is explained by pathophysiologic processes, and treatments are designed to affect these processes. The term biopsychosocial medicine has long been used to describe a biomedical model that recognizes the importance of psychosocial factors.7 Biomedical treatments are based on accumulated evidence of effectiveness from peer-reviewed scientific research. There is a hierarchy of research evidence, at the top of which is the controlled clinical trial. Many accepted biomedical treatments lack evidence of effectiveness from controlled clinical trials (eg, the use of physical therapy in the care of the premature infant). Unproven therapies also may be based on pathophysiology and limited research, but they lack accepted standards of proven effectiveness (eg, the use of immunoglobulins in the treatment of autism).8 Alternative therapies are based on a variety of nonbiomedical beliefs and usually have not been subjected to clinical research. Most are supported by anecdotal evidence, but some alternative therapies have proven effectiveness. For example, preliminary studies of acupuncture in addiction treatment show positive results.9 In time, such proven therapies may come into wider use and lose their "alternative" status.
Biopsychosocial medicine and CAM have at least one thing in common: both recognize that the relationship between physician-healer and patient is integral to the success of treatments offered. This is part of the age-old "art" of medicine and is a basis of the placebo response.10 The emphasis of biomedicine on pathophysiology and on technical outcomes has reinforced the perception among some families that physicians undervalue their relationships with their patients. The failure of biomedicine to recognize and respond adequately to individual differences among patients is one reason families turn elsewhere and has contributed to the increasing use of CAM.
The distinctions among unproven therapies, CAM, and biomedicine may become especially blurred in the care of children with chronic illness or disability. Some conventional biomedical therapies lack proof of effectiveness, and some unproven and alternative therapies may in time prove effective. Also, some alternative therapies conceivably may have placebo effects, which confer additional therapeutic gain and enhanced quality of life. These factors may present significant challenges to the health care professional. Moreover, there are no published clinical guidelines regarding the use of CAM in the care of children with chronic illness or disability.11
| |
WHY PARENTS OF CHILDREN WITH CHRONIC ILLNESS OR DISABILITY CHOOSE CAM |
|---|
Parental questioning of a child's diagnosis, treatment, and prognosis reflects a normal process of adjustment to the permanence or chronicity of the condition and the desire to ensure the best possible outcome for their child. Many parents become frustrated with biomedical therapies because of complexity, discomfort, bewildering technology, or uncertainty of cure. Indeed, for some conditions, biomedicine has little or nothing to offer. Also, families may be frustrated because they have not been sufficiently involved in the development of a care plan. The media, condition-specific publications, and parent-to-parent contacts provide essential opportunities for families to learn about resources, including CAM. Furthermore, the Internet has dramatically increased exposure of families to sophisticated marketing, testimonials, and unproven claims. Some parents are attracted to simple explanations of causality, some by an approach perceived to be more "natural." Many try a succession of alternative therapies, believing that any approach that does no harm is worth a trial. For almost all, CAM approaches represent an attempt to gain a sense of control over their child's chronic illness or disability and to improve quality of life.
| |
BALANCING FAMILY-CENTERED CARE WITH THE ETHICAL RESPONSIBILITY OF THE PEDIATRICIAN |
|---|
The "medical home" concept emphasizes that care should be compassionate and family-centered. Mutual participation in decision making and informed consent are essential elements of respectful care.12 Decisions and plans should be made through a process of collaborative decision making in which the family receives complete and unbiased information needed to understand and make informed decisions. The quality of the relationship between the health care professional and patient with chronic illness has been shown clearly to affect outcomes.13 Honest and supportive relationships with health care professionals can help parents cope14 and promote the child's independence.15 Such relationships are strengthened when health care professionals understand the perspectives of the family, provide care with flexibility, and attempt to meet the family's needs and expectations. Clearly, it is optimal for children with chronic illness or disability to receive health care in a setting that is family-centered. At the same time, pediatricians have an ethical responsibility to guard the welfare of children by ensuring that any treatment they endorse is "in accordance with science and proven experience."16,17 Dilemmas may arise when families ask their pediatrician to endorse or to provide a therapy that is considered by the pediatrician not to be in the best interests of the child. There may be evidence of the possibility of direct harm, unknown risks, or concerns about indirect harm to the child. The pediatrician is in a position to balance a commitment to family-centered care with the ethical responsibility to guard the welfare of children.18,19
| |
SUMMARY/CONCLUSION |
|---|
|
|
|---|
The use of CAM approaches in the United States is increasing, especially among children with chronic illness or disability. Distinctions among unproven therapies, CAM, and biomedicine may become blurred, presenting special challenges to the pediatrician. To best serve the interests of children, it is important to provide balanced advice about therapeutic options, to guard against bias, and to establish and maintain a trusting relationship with families. Although the focus of this statement is chronic illness or disability, the recommendations that follow also may apply to the use of alternative medicine in other pediatric domains.
| |
RECOMMENDATIONS FOR PEDIATRICIANS WHO DISCUSS ALTERNATIVE, COMPLEMENTARY, AND UNPROVEN THERAPIES WITH FAMILIES |
|---|
- Seek information for yourself and be prepared to share it
with families.
Families are likely to be appreciative of information you have obtained through literature searches. Reviews of CAM discuss currently popular alternative approaches and their attendant risks.3,20-22 Also, Appendix I shows several Web sites that may be useful resources. - Evaluate the scientific merits of specific therapeutic
approaches.
Critical evaluation of claims of effectiveness requires training in the scientific method and an understanding of processes of disease. This training is equally important for evaluating conventional biomedical treatments and alternative therapies. Many CAM approaches are based on inconsistent or implausible biomedical explanations, and claims of effectiveness rest on anecdotal information and testimonials. The pediatrician can be uniquely helpful to parents seeking an assessment of the merits of specific therapies by evaluating such therapies and providing guidance. - Identify risks or potential harmful effects.
Alternative therapies may be directly harmful by causing direct toxic effects, compromising adequate nutrition, interrupting beneficial medications or therapies, or postponing biomedical therapies of proven effectiveness. Indirect harm may be caused by the financial burden of the alternative therapy, other unanticipated costs (eg, the time investment required to administer the therapy), and feelings of guilt associated with inability to adhere to rigorous treatment demands. If a child receiving alternative therapy is at direct or indirect risk of harm, the pediatrician should advise against the therapy. In some circumstances, it may be necessary for the pediatrician to seek an ethics consultation or to refer to child welfare agencies. If there is no risk of direct or indirect harm, a pediatrician should be neutral. - Provide families with information on a range of treatment
options (avoid therapeutic nihilism).
Although effective treatments to cure the underlying condition or restore function may be lacking, there may be adjunctive treatments to improve quality of life, address specific concerns of the child or family, or modify environmental conditions that may be causing additional problems. Consultation with pediatric specialists may suggest therapeutic options. Discussion of a range of treatment options may avert feelings of frustration and powerlessness that drive families to alternative sources of care. - Educate families to evaluate information about all treatment
approaches.
Families should be informed about placebo effects and the need for controlled studies. The pediatrician should explain that anecdotal and testimonial evidence is very weak. Families also should be advised to be vigilant for exaggerated claims of cure, especially if such claims are for treatments requiring intense commitment of time, energy, and money on the part of the family. - Avoid dismissal of CAM in ways that communicate a lack of
sensitivity or concern for the family's perspective.
Some alternative therapies considered by families may warrant independent review and evaluation of scientific merit by the pediatrician. Respectful family-centered care rests on the pediatrician's willingness to listen carefully and to acknowledge the family's concerns, priorities, and fears, including social and cultural factors that may affect their choice of therapies. If CAM is chosen against the advice of the pediatrician, he or she should continue to offer care to the child. - Recognize feeling threatened and guard against becoming
defensive.
Families may express their opinions in ways that challenge the professional expertise of the pediatrician. They may bring to the discussion of CAM a number of biased assumptions that contribute to an atmosphere of distrust and an adversarial relationship. It may be helpful for the pediatrician to make empathic statements that acknowledge the families' deep concerns, thereby avoiding angry or defensive reactions. - If the CAM approach is endorsed, offer to assist in monitoring
and evaluating the response.
The pediatrician can help to establish clinical outcomes and target behaviors or symptoms that can be observed and measured. Sometimes, the pediatrician and family can agree on a time-limited trial of the proposed approach. - Actively listen to the family and the child with chronic
illness.
The pediatrician should be aware of their concerns, their understanding of the condition, and their needs for support. Support groups and community networks can greatly enhance family comfort with the management of the chronic illness or disability.
Committee on Children With Disabilities, 2000-2001
Adrian D. Sandler, MD, Chairperson
Dana Brazdziunas, MD
W. Carl Cooley, MD
Lilliam González de Pijem, MD
David Hirsch, MD
Theodore A. Kastner, MD
Marian E. Kummer, MD
Richard D. Quint, MD, MPH
Elizabeth S. Ruppert, MD
Liaisons
Polly Arango
Family Voices
Paul Burgan, MD, PhD
Social Security Administration
Connie Garner, RN, MSN, EdD
US Dept of Education
Merle McPherson, MD
Maternal and Child Health Bureau
Linda Michaud, MD
American Academy of Physical Medicine and Rehabilitation
Marshalyn Yeargin-Allsopp, MD
Centers for Disease Control and Prevention
Section Liaisons
J. Daniel Cartwright, MD
Section on School Health
Chris P. Johnson, MEd, MD
Section on Children With Disabilities
Staff
Karen Smith
| |
APPENDIX I |
|---|
Helpful Resources on the Internet
- University of Texas Center for Alternative Medicine Research, http://www.sph.uth.tmc.edu/utcam/default.htm
- The National Institutes of Health Office of Alternative Medicine, http://altmed.od.nih.gov/
- The National Council for Reliable Health Information, http://www.ncahf.org
- The Consumer Federation of America, http://www.quackwatch.com
| |
FOOTNOTES |
|---|
The recommendations in this statement do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.
| |
ABBREVIATIONS |
|---|
CAM, complementary and alternative medicine.
| |
REFERENCES |
|---|
|
|
|---|
-
Eisenberg DM,
Kessler RC,
Foster C,
Norlock FE,
Calkins DR,
Delbanco TL
Unconventional medicine in the United States: prevalence,
costs, and patterns of use.
N Engl J Med
1993;
328:246-252
[Abstract/Free Full Text] -
Eisenberg DM,
Davis RB,
Ettner SL,
Trends in alternative
medicine use in the United States, 1990-1997: results of a follow-up
national survey.
JAMA.
1998;
280:1569-1575
[Abstract/Free Full Text] - Nickel RE Controversial therapies for young children with developmental disabilities. Infants Young Child 1996; 8:29-40
- Panel of Definition and Description, CAM Research Methodology Conference, April 1995. Defining and describing complementary and alternative medicine. Altern Ther Health Med. 1997;1995:3:49-57
-
Wetzel MS,
Eisenberg DM,
Kaptchuk TJ
Courses involving complementary
and alternative medicine at US medical schools.
JAMA
1998;
280:784-787
[Abstract/Free Full Text] - National Center for Complementary and Alternative Medicine (NCCAM). General Information about CAM and the NCCAM. Bethesda, MD: National Institutes of Health; 2000
-
Engel GL
The clinical application of the biopsychosocial model.
Am J Psychiatr
1980;
137:535-544
[Abstract/Free Full Text] - Gupta S, Aggarwal S, Heads C Dysregulated immune-system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. Autism Developmental Disord 1996; 26:439-452
- Brewington V, Smith M, Lipton D Acupuncture as a detoxification treatment: an analysis of controlled research. J Subst Abuse Treat 1994; 11:289-307 [CrossRef][Medline]
- Harrington A, ed. The Placebo Effect: An Interdisciplinary Exploration. Cambridge, MA: Harvard University Press; 1997
-
Practice and Policy Guidelines Panel, National Institutes of Health
Office of Alternative Medicine
Clinical practice guidelines in
complementary and alternative medicine: an analysis of opportunities
and obstacles.
Arch Fam Med
1997;
6:149-154
[Abstract/Free Full Text] - Barber B Compassion in medicine: toward new definitions and new institutions. N Engl J Med 1976; 295:939-943 [Medline]
- Kaplan SH, Greenfield S, Ware JE Jr Assessing the effects of physician-patient interactions on the outcomes of chronic disease [published correction appears in Med Care. 1989;27:679]. Med Care 1989; 27:S110-S127 [Medline]
- Frey KS, Fewell RR, Vadasy PF Parental adjustment and changes in child outcome among families of young handicapped children. Top Early Child Special Education 1989; 8:38-57 [CrossRef]
- Gordon N Independence for the physically disabled. Child Care Health Dev 1992; 18:97-105 [CrossRef][Medline]
- Roth RB. Medicine's ethical responsibilities. In: Veatch RM, ed. Cross Cultural Perspectives in Medical Ethics: Readings. Boston, MA: Jones and Bartlett Publishers; 1989;150-155
- Lynoe N Ethical and professional aspects of the practice of alternative medicine. Scand J Soc Med 1992; 20:217-225 [Medline]
-
Eisenberg DM
Advising patients who seek alternative medical therapies.
Ann Intern Med
1997;
127:61-69
[Abstract/Free Full Text] -
Sugarman J,
Burk L
Physicians' ethical obligations regarding
alternative medicine.
JAMA
1998;
280:1623-1625
[Free Full Text] - Spigelblatt LS Alternative medicine: should it be used by children? Curr Probl Pediatr 1995; 25:180-188 [Medline]
- Fugh-Berman A. Alternative Medicine: What Works. Baltimore, MD: Williams & Wilkins; 1997
- Kemper KJ Separation or synthesis: a holistic approach to therapeutics. Pediatr Rev 1996; 17:279-283
Pediatrics (ISSN 0031 4005). Copyright ©2001 by the American Academy of Pediatrics
Statement of reaffirmation:
- AAP Publications Retired and Reaffirmed
- American Academy of Pediatrics
Pediatrics 2005 115: 1438.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
![]() |
A. Golnik, M. Ireland, and I. W. Borowsky Medical Homes for Children With Autism: A Physician Survey Pediatrics, March 1, 2009; 123(3): 966 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Kemper, S. Vohra, R. Walls, the Task Force on Complementary and Alternative Me, and the Provisional Section on Complementary, Holistic The Use of Complementary and Alternative Medicine in Pediatrics Pediatrics, December 1, 2008; 122(6): 1374 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Johnson Recognition of Autism Before Age 2 Years Pediatr. Rev., March 1, 2008; 29(3): 86 - 96. [Full Text] [PDF] |
||||
![]() |
S. M. Myers, C. P. Johnson, and the Council on Children With Disabilities Management of Children With Autism Spectrum Disorders Pediatrics, November 1, 2007; 120(5): 1162 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Brachlow, K. K. Ness, M. L. McPheeters, and J. G. Gurney Comparison of Indicators for a Primary Care Medical Home Between Children With Autism or Asthma and Other Special Health Care Needs: National Survey of Children's Health Arch Pediatr Adolesc Med, April 1, 2007; 161(4): 399 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kelly, K. J. Kemper, and L. D. Rosen The Role of Pediatricians Who Care for Children With Autism Arch Pediatr Adolesc Med, April 1, 2007; 161(4): 416 - 417. [Full Text] [PDF] |
||||
![]() |
A. Sawni, R. Ragothaman, R. L. Thomas, and P. Mahajan The Use of Complementary/Alternative Therapies Among Children Attending an Urban Pediatric Emergency Department Clinical Pediatrics, January 1, 2007; 46(1): 36 - 41. [Abstract] [PDF] |
||||
![]() |
J. W. Harrington, P. A. Patrick, K. S. Edwards, and D. A. Brand Parental beliefs about autism: Implications for the treating physician Autism, September 1, 2006; 10(5): 452 - 462. [Abstract] [PDF] |
||||
![]() |
V. C.N. Wong, J.-G. Sun, and D. W.C. Yeung Pilot Study of Positron Emission Tomography (PET) Brain Glucose Metabolism to Assess the Efficacy of Tongue and Body Acupuncture in Cerebral Palsy J Child Neurol, June 1, 2006; 21(6): 455 - 462. [Abstract] [PDF] |
||||
![]() |
M. H. Cohen, K. J. Kemper, L. Stevens, D. Hashimoto, and J. Gilmour Pediatric Use of Complementary Therapies: Ethical and Policy Choices Pediatrics, October 1, 2005; 116(4): e568 - e575. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Cohen and K. J. Kemper Complementary Therapies in Pediatrics: A Legal Perspective Pediatrics, March 1, 2005; 115(3): 774 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Cooley and and Committee on Children with Disabilities Providing a Primary Care Medical Home for Children and Youth With Cerebral Palsy Pediatrics, October 1, 2004; 114(4): 1106 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L de Lemos, L. John, L. Nakashima, R. K. O'Brien, and S. C. Taylor Advising Cancer Patients on Natural Health Products--A Structured Approach Ann. Pharmacother., September 1, 2004; 38(9): 1406 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. S. Sibinga, M. C. Ottolini, A. K. Duggan, and M. H. Wilson Parent-Pediatrician Communication about Complementary and Alternative Medicine Use for Children Clinical Pediatrics, May 1, 2004; 43(4): 367 - 373. [Abstract] [PDF] |
||||
![]() |
Subcommittee on Management of Acute Otitis Media Diagnosis and Management of Acute Otitis Media Pediatrics, May 1, 2004; 113(5): 1451 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ente Prevalence of Complementary and Alternative Medicine Use in US Children Arch Pediatr Adolesc Med, March 1, 2004; 158(3): 292 - 292. [Full Text] [PDF] |
||||
![]() |
A. D. Woolf Herbal Remedies and Children: Do They Work? Are They Harmful? Pediatrics, July 1, 2003; 112(1): 240 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee on Pediatric Workforce Scope of Practice Issues in the Delivery of Pediatric Health Care Pediatrics, February 1, 2003; 111(2): 426 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weinstein and S. Bernstein Pink ladies: mercury poisoning in twin girls Can. Med. Assoc. J., January 21, 2003; 168(2): 201 - 201. [Full Text] [PDF] |
||||
![]() |
B. Bouch and D. S. McWaters Inadequate Internet Resources Cited Pediatrics, November 1, 2001; 108(5): 1237 - 1238. [Full Text] |
||||
![]() |
M. Shannon, S. E. Levy, and A. Sandler Chelation therapy neither safe nor effective as autism treatment AAP News, August 1, 2001; 19(2): 63 - 63. [Full Text] [PDF] |
||||
![]() |
Committee on Children With Disabilities Technical Report: The Pediatrician's Role in the Diagnosis and Management of Autistic Spectrum Disorder in Children Pediatrics, May 1, 2001; 107(5): 85e - 85. [Abstract] [Full Text] |
||||
![]() |
L. O'Keefe Weigh alternate treatment options for children with disabilities or chronic illness AAP News, March 1, 2001; 18(3): 128 - 129. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||










